Home / Education / Education Courses / 2nd Annual Conference on Psychedelics and Psychedelic Medicine

2nd Annual Conference on Psychedelics and Psychedelic Medicine

Event Date(s): Nov 4, 2022 - 08:00am to Nov 5, 2022 - 05:10pm

We invite you to join us at the Westin Copley place in Boston for our 2nd Annual Conference on Psychedelics and Psychedelic Medicine conference. This conference will provide up-to-date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice.

Register For This Course

Course Details

We invite you to join us at the Westin Copley place in Boston for our 2nd Annual Conference on Psychedelics and Psychedelic Medicine conference. This conference will provide up-to-date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice. Mechanisms of action including pharmacology, neuroscience, psychodynamic theory will be discussed, with a focus on specific clinical entities such as depression, PTSD, an addictions. Additional panel discussions and presentations will explore history, ethics, cultural issues, plant medicine, and many other relevant topics within the rapidly growing field of psychedelic medicine.

Pricing

MDs/Doctoral-Level Professionals

Super Early Bird Registration (on or before August 26, 2022) $620.00
Early Bird Registration (on or before September 30, 2022) $650.00
Regular Registration (after September 30, 2022) $675.00

Other Professionals or Trainees

Super Early Bird Registration (on or before August 26, 2022) $525.00
Early Bird Registration (on or before September 30, 2022) $575.00
Regular Registration (after September 30, 2022) $620.00

Residents & Medical Students: $150.00

***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.

 


Syllabus

The conference syllabus is a printed book with all slide presentations and space to take notes adjacent to each slide.

Syllabus Book: $50

E-SYLLABUS
We provide all attendees  with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference. 
 


Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by October 30, 2022.  No refunds will be issued for refund requests made after October 30, 2021. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.

Course Summary

Course Topic:Conference, Psychopharmacology
Course Format:Conference
Target Audience:

This program is intended for mental health practitioners including psychiatrists, psychiatric nurse practitioners, social workers and clinical psychologists.

Event Starts: Nov 4, 2022 - 08:00am
Event Ends: Nov 5, 2022 - 05:10pm
Cost: $675.00

Learning Objectives

By the end of this program, participants will be able to:

  • Describe the history of psychedelic-assisted therapy within psychiatry, including aspects of medical and medico-cultural history
  • Compare different models of psychedelic-assisted psychotherapy (eg, psycholytic vs psychedelic)
  • List key psychiatric entities for which psychedelics have already shown promise, as well as specific studies in patient populations (such as for MDD)
  • Explain the neuropsychopharmacology of classical psychedelics as well as atypical psychedelics such as ketamine and empathogens such as MDMA
  • Apply contemporary neuroimaging research to understand key hypotheses for brain-based mechanisms of action of psychedelics in normal and clinical populations
  • Explain research using psychedelic-assisted psychotherapy for depression and anxiety disorders
  • Utilize existing evidence in the understanding of how psychedelics might be effective for the treatment of substance use disorders
  • Identify hypotheses for mechanisms of action of psychedelics on the brain, based on recent neuroimaging studies
  • Critique contemporary medico-cultural issues within psychedelic research, including race-based structural biases and epistemic injustice
  • Describe challenges within training and education for the field of psychedelic-assisted therapy
  • List and discuss potential risks of psychedelics, including risks of psychedelic-assisted therapy and challenges to accurately researching the effects of these therapies
  • Assess potential applications of psychedelic-assisted therapy in extra-psychiatric fields, such as within palliative care and spirituality, as well as within medicine, such as for pain and immunomodulation
  • Identify the role of plant medicines and how these understandings might inform next generations of treatments in 21st century medicine